Postmenopausal osteoporosis.
D045930:Anabolic Agents / Q000627:therapeutic use; D001018:Aortic Diseases / Q000209:etiology; D001706:Biopsy; D001827:Body Height; D001842:Bone and Bones / Q000473:pathology; D002114:Calcinosis / Q000209:etiology; D002118:Calcium / Q000652:urine; D003480:Cushing Syndrome / Q000175:diagnosis; D003937:Diagnosis, Differential; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000209:etiology; D006801:Humans; D007006:Hypogonadism / Q000150:complications; D007103:Immobilization; D007738:Kyphosis / Q000209:etiology; D008593:Menopause; D009101:Multiple Myeloma / Q000175:diagnosis; D009397:Nephrocalcinosis / Q000209:etiology; D010024:Osteoporosis / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D011859:Radiography; D013124:Spinal Injuries / Q000209:etiology; D013125:Spinal Neoplasms / Q000175:diagnosis
D045930:Anabolic Agents; D004966:Estrogens, Conjugated (USP); D002118:Calcium